459841-23-7

Upstream product

• 95-65-8 3,4-Dimethylphenol 
• 104447-92-9 4-bromomethyl-3-methylbenzoic acid methyl ester 
• 17100-58-2 4-bromo-2-methylbenzyl alcohol 
• 68837-59-2 4-bromo-2-methylbenzoic acid 
• 18087-10-0 4,5-dimethyl-2-nitrophenol 
• 24078-25-9 4-hydroxymethyl-3-methylbenzoic acid methyl ester 

Downstream Products

• 916913-92-3 methyl 4-({4,5-dimethyl-2-[(1,3-thiazol-2-ylsulfonyl)amino]phenoxy}methyl)-3-methylbenzoate 
• 459841-24-8 3-methyl-4-[2-[N-(5-methyl-2-furylsulfonyl)amino]-4,5-5-dimethylphenoxymethyl]benzoic acid methyl ester 
• 916914-01-7 methyl 4-({2-[isobutyl(1,3-thiazol-2-ylsulfonyl)amino]-4,5-dimethylphenoxy}methyl)-3-methylbenzoate 
• 459841-26-0 3-methyl-4-[2-[N-isobutyl-N-(5-methyl-2-furylsulfonyl)amino]-4,5-5-dimethylphenoxymethyl]benzoic acid 
• 459841-25-9 3-methyl-4-[2-[N-isobutyl-N-(5-methyl-2-furylsulfonyl)amino]-4,5-5-dimethylphenoxymethyl]benzoic acid methyl ester 

Relevant academic research and scientific papers

Optimization of sulfonamide derivatives as highly selective EP1 receptor antagonists

A series of 4-[(2-{isobutyl[(5-methyl-2-furyl)sulfonyl]amino}phenoxy)methyl]benzoic acids and 4-({2-[isobutyl(1,3-thiazol-2-ylsulfonyl)amino]phenoxy}methyl)benzoic acids were synthesized and evaluated for their EP receptor affinities and EP1 receptor anta